Blood News and Research

RSS

The App That's Transforming Blood Banking

An interview with Celia Tombalankian, discussing the benefits of automation in blood banking and the development of a new blood banking app.

From Ortho-Clinical Diagnostics, Inc. 29 Oct 2012

Improvements in rare cell isolation and common blood tests

At the Sixteenth International Conference on Miniaturized Systems for Chemistry and Life Sciences (microTAS) to be held Oct. 28-Nov. 1, in Okinawa, Japan, University of Cincinnati researchers will present four papers, including one detailing improvements in rare cell isolation and one detailing improvements, in terms of cost and time, of common blood tests.

29 Oct 2012

Maternal bariatric surgery affects cardiovascular risk profile of offsprings

Kids born to moms who have lost a substantial amount of weight after undergoing bariatric surgery have fewer cardiovascular risk factors than their siblings who were born before the weight loss surgery.

29 Oct 2012

Drug company to pay $95M to settle allegations of improper promotions for three drugs

Boehringer Ingelheim Pharmaceuticals Inc. will pay $95 million to settle allegations that the company promoted three drugs for uses that were not medically accepted, the government announced Thursday.

29 Oct 2012

Haemonetics second quarter 2013 net revenue increases 22% to $218.2 million

Haemonetics Corporation today reported second quarter 2013 net revenue of $218.2 million, up 22%, GAAP net income of $6.5 million, down 53%, and diluted earnings per share of $0.25, down 53%.

29 Oct 2012

Routine ECG can help doctors identify patients at higher risk of adverse cardiovascular outcomes

Canadian scientists have determined that routine electrocardiogram results for patients with atrial fibrillation - the most common form of irregular heart beat - can help doctors identify those at higher risk of adverse cardiovascular outcomes, including death.

29 Oct 2012

UK remains at risk of devastating stroke crisis, new report confirms

The UK remains at risk of a devastating stroke crisis, according to UK health experts launching Reports published today, on World Stroke Day, by Action for Stroke Prevention, an alliance of renowned health experts and patient organisations.

29 Oct 2012

Neuraxial anesthesia should be promoted for bilateral total knee replacements: HSS

Using regional anesthesia rather than general anesthesia reduces the need for blood transfusions in patients undergoing bilateral total knee replacement, according to a new study by researchers at Hospital for Special Surgery, in New York City.

29 Oct 2012

Research team receives grant to study impact of urban air pollution on TB immunity

An international team of researchers, led by Stephan Schwander, MD, PhD, director of the Center for Global Public Health at the University of Medicine and Dentistry of New Jersey-School of Public Health, has received a $2.96 million grant to conduct a "real-world" study on the impact of urban air pollution on the human immune system's ability to resist Mycobacterium tuberculosis, the bacterium that causes tuberculosis.

29 Oct 2012

New HIV test for babies differs from conventional test, delivers diagnosis in less than an hour

Today, mothers in Africa sometimes walk more than 10 miles to a clinic only to learn that conventional HIV test results for their babies are not available yet.

29 Oct 2012

Scientists develop new prototype ultra sensitive disease sensor

Scientists have developed a prototype ultra-sensitive sensor that would enable doctors to detect the early stages of diseases and viruses with the naked eye, according to research published today in the journal Nature Nanotechnology.

29 Oct 2012

New findings on early treatment of ADHD patients presented at AACAP 2012 conference

Mayo Clinic researchers are presenting new findings on the early treatment of child and adolescent attention deficit hyperactivity disorder this week at the American Academy of Childhood and Adolescent Psychiatry annual meeting in San Francisco.

29 Oct 2012

High-intensity interval training makes middle-aged people smarter

High-intensity interval training makes middle-aged people not only healthier but smarter, showed a Montreal Heart Institute (MHI) study led by Dr. Anil Nigam of the MHI and University of Montreal, in collaboration with the Montreal Geriatric University Institute.

29 Oct 2012

Chemists' innovation may be a better model for disease diagnostic kits

When someone develops liver cancer, the disease introduces a very subtle difference to their bloodstream, increasing the concentration of a particular molecule by just 10 parts per billion.

29 Oct 2012

Scientists identify mechanism via Top2b enzyme that drives doxorubicin-induced heart damage

Doxorubicin, a 50-year-old chemotherapy drug still in widespread use against a variety of cancers, has long been known to destroy heart tissue, as well as tumors, in some patients.

29 Oct 2012

Resistin protein causes high levels of bad cholesterol

Canadian scientists have discovered that a protein called resistin, secreted by fat tissue, causes high levels of "bad" cholesterol (low-density lipoprotein or LDL), increasing the risk of heart disease.

29 Oct 2012

Results of diabetes management program to be presented at Canadian Cardiovascular Congress

In Canada alone, almost 2 million people are known to be living with diabetes. And around a million more have the disease but are not aware of that fact, and have not been given the tools they need to control their blood sugar and safeguard their health.

29 Oct 2012

Mouse model may provide clues on mechanism that links diabetes and aging to Alzheimer's

Growing evidence suggests that there may be a link between diabetes and Alzheimer's disease, but the physiological mechanisms by which diabetes impacts brain function and cognition are not fully understood. In a new study published in Aging Cell, researchers at the Salk Institute for Biological Studies show, for the first time, that diabetes enhances the development of aging features that may underlie early pathological events in Alzheimer's.

29 Oct 2012

Europe remains at risk of a devastating stroke crisis

Europe remains at risk of a devastating stroke crisis, according to a major new Report, "How Can We Avoid a Stroke Crisis in Europe?" published today, on World Stroke Day, by Action for Stroke Prevention (ASP).

29 Oct 2012

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

29 Oct 2012

Blood News and Research

The App That's Transforming Blood Banking

Improvements in rare cell isolation and common blood tests

Maternal bariatric surgery affects cardiovascular risk profile of offsprings

Drug company to pay $95M to settle allegations of improper promotions for three drugs

Haemonetics second quarter 2013 net revenue increases 22% to $218.2 million

Routine ECG can help doctors identify patients at higher risk of adverse cardiovascular outcomes

UK remains at risk of devastating stroke crisis, new report confirms

Neuraxial anesthesia should be promoted for bilateral total knee replacements: HSS

Research team receives grant to study impact of urban air pollution on TB immunity

New HIV test for babies differs from conventional test, delivers diagnosis in less than an hour

Scientists develop new prototype ultra sensitive disease sensor

New findings on early treatment of ADHD patients presented at AACAP 2012 conference

High-intensity interval training makes middle-aged people smarter

Chemists' innovation may be a better model for disease diagnostic kits

Scientists identify mechanism via Top2b enzyme that drives doxorubicin-induced heart damage

Resistin protein causes high levels of bad cholesterol

Results of diabetes management program to be presented at Canadian Cardiovascular Congress

Mouse model may provide clues on mechanism that links diabetes and aging to Alzheimer's

Europe remains at risk of a devastating stroke crisis

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News